[SO/URSA-PHARM] Patient Timelines of PDC Medication Supply
- 27 Jun 2025
- 1 Minute to read
- Print
- DarkLight
[SO/URSA-PHARM] Patient Timelines of PDC Medication Supply
- Updated on 27 Jun 2025
- 1 Minute to read
- Print
- DarkLight
Article summary
Did you find this summary helpful?
Thank you for your feedback!
Object Description
Patient timeline with one record per period during which the patient is in a medication therapy episode for a PDC medication; the purpose of this object is to avoid double-counting supply when patients are on multiple families of medications within the same PDC category.
Metadata
- Table Name: ursa.so_ursa_pharm_meds_102
- Layer: SYNTHETIC_OBJECT
- Object Type: Complex Timeline
- Temporal Class: Interval (Timeline)
- Case ID: Patient ID
- Interval Start Date: Period Start Date
- Interval End Date: Period End Date
- Primary Key: Patient ID, Period Start Date, Period End Date
Published Fields
Data Model Keys
- Patient ID -- The internal database identifier (used, e.g., for joins and primary keys) for the patient. This value is typically mastered, i.e., all records for the same patient, regardless of the source data system from which that record originated, should have the same Patient ID value. (Note that while the mastered Patient ID value might resemble a local identifier used in one of the upstream data sources, this does not indicate any special priority of that source system in determining the characteristics of the patient.) (See also [URSA-CORE] Patient)
Date Fields
- Period Start Date
- Period End Date
Module Fields
- Is Oral Antidiabetic -- A child to the "Is Antidiabetic" medication type, indicates antidiabetic medications that can be taken orally as opposed other routes of administration (such as injections). Oral Antidiabetics are commonly separated from all antidiabetics for various adherence/quality measures (e.g., Stars PDC). (See also [URSA-PHARM] Antidiabetic)
- Is Oral ACEI/ARB -- One of the Priority Adherence Medication types; indicates a medication classified as a angiotensin-converting enzyme inhibitor (ACEI) and an angiotensin receptor blocker (ARB) based on the Red Book Generic Cross Reference code and/or NDC being included in the CMS Stars measure specifications for Oral ACEI/ARB PDC measures. (See also [URSA-PHARM] Is Priority Adherence Medication, [URSA-PHARM] Active Priority Adherence Medication Type Category)
- Is Statin -- One of the Priority Adherence Medication types; indicates a medication classified as a Statin based on the Red Book Generic Cross Reference code and/or NDC being included in the CMS Stars Statin proportion of days covered (PDC) measure value sets. (See also [URSA-PHARM] Is Priority Adherence Medication)
- Count Distinct Oral Antidiabetics
- Count Distinct Oral ACEI/ARBs
- Count Distinct Statins
Foreign Keys
- pat_id → ursa.no_ursa_core_pat_001.pat_id
Was this article helpful?